| Terminated | A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy Symptomatic Neurogenic Orthostatic Hypotension, Parkinson's Disease, Multiple Systems Atrophy | Phase 3 | 2013-11-01 |
| Withdrawn | A Multi-Center, Open-Label Study Renal Disease, End Stage Renal Disease | Phase 1 | 2012-10-01 |
| Withdrawn | Study to Assess Droxidopa in the Treatment of Freezing Of Gait Symptoms in Patients With Parkinson's Disease Gait Disorders, Neurologic | Phase 1 / Phase 2 | 2012-04-01 |
| Completed | Electrocardiographic (ECG) Safety Study of Droxidopa at Clinical and Supratherapeutic Dose QTc Interval | Phase 1 | 2011-03-01 |
| Completed | A Study of CH-4051 in Patients With Rheumatoid Arthritis (RA) Rheumatoid Arthritis | Phase 2 | 2010-09-01 |
| Terminated | Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue Syndrome Chronic Fatigue Syndrome, Orthostatic Hypotension, Neurally Mediated Hypotension | Phase 2 | 2010-07-01 |
| Completed | Study of the Fed-Fast Pharmocokinetics and Bioequivalance of 300mg Capsules of Droxidopa Symptomatic Neurogenic Orthostatic Hypotension | Phase 1 | 2010-07-01 |
| Completed | A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease Orthostatic Hypotension, Parkinson's Disease | Phase 3 | 2010-06-01 |
| Completed | Study of Droxidopa Treatment in Adults With Attention Deficit Hyperactivity Disorder With Co-administration of Attention Deficit Hyperactivity Disorder | Phase 2 | 2009-10-01 |
| Completed | Study To Assess The Clinical Benefit Of Droxidopa And Droxidopa/Carbidopa In Subjects With Fibromyalgia Fibromyalgia | Phase 2 | 2009-01-01 |
| Completed | Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304) Primary Autonomic Failure, Dopamine Beta Hydroxylase Deficiency, Non-Diabetic Neuropathy | Phase 3 | 2009-01-01 |
| Completed | A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa Symptomatic Neurogenic Orthostatic Hypotension (NOH), Non-diabetic Neuropathy, Primary Autonomic Failure | Phase 3 | 2008-09-01 |
| Completed | A Study to Assess CH1504 in Patients With Active Rheumatoid Arthritis Arthritis, Rheumatoid | Phase 2 | 2008-04-01 |
| Completed | Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) Symptomatic Neurogenic Orthostatic Hypotension (NOH), Non-diabetic Neuropathy, Primary Autonomic Failure | Phase 3 | 2008-01-01 |
| Completed | Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) Neurogenic Orthostatic Hypotension, Non-Diabetic Autonomic Neuropathy, Multiple System Atrophy | Phase 3 | 2008-01-01 |
| Completed | Safety and Benefit Study of Droxidopa to Treat Patients With Intradialytic Hypotension Intradialytic Hypotension | Phase 2 | 2007-12-01 |